RFA
GSK icon

Register Financial Advisors’s GSK GSK Stock Holding History

Register Financial Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-738
Closed -$28.4K – 478
2024
Q2 		$28.4K Buy
738
+6
+0.8% +$252 0.01% 412
2024
Q1 		$31.4K Buy
+732
New +$30.2K 0.02% 401
2023
Q4 		– Sell
-554
Closed -$20.1K – 445
2023
Q3 		$20.1K Sell
554
-354
-39% -$12.6K 0.01% 343
2023
Q2 		$32.4K Buy
908
+5
+0.6% +$179 0.02% 291
2023
Q1 		$32.1K Sell
903
-1,096
-55% -$38.3K 0.03% 285
2022
Q4 		$70.2K Buy
+1,999
New +$66.6K 0.04% 306

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Register Financial Advisors's GSK Position: Q3 2024 in Review

Register Financial Advisors sold out of GSK (GSK) in Q3 2024, closing a stake of 738 shares — an estimated $28.4K sold.

Register Financial Advisors first reported a position in GSK in Q4 2022 and held it in 6 quarters. The position peaked at $70.2K in Q4 2022. 899 funds tracked by Wall St. Rank hold GSK as of Q3 2024.

  • Register Financial Advisors reported no remaining GSK position as of Q3 2024 after selling out during the quarter.
  • Register Financial Advisors sold 738 GSK shares in Q3 2024, an estimated $28.4K.
  • Register Financial Advisors first reported a position in GSK in Q4 2022 and held it in 6 quarters.
  • Register Financial Advisors's GSK position peaked at $70.2K in Q4 2022.
  • 899 funds tracked by Wall St. Rank held GSK as of Q3 2024.

Based on Register Financial Advisors's 13F filing for Q3 2024, filed 15 Oct 2024.